title: Response of bone metabolism related hormones to a single session of strenuous exercise in active elderly subjects.
abstract: OBJECTIVE
  To evaluate the effect of strenuous exercise on bone metabolism and related hormones in elderly subjects.
  
  
  METHODS
  Twenty one active elderly subjects (11 men and 10 women; mean age 73.3 years) showing a mean theoretical Vo2max of 151.4% participated. Concentrations of plasma ionised calcium (iCa), serum intact parathyroid hormone (iPTH), 25-hydroxyvitamin D (25(OH)D), and 1.25-dihydroxy-vitamin D3 (1.25(OH)2D3), as well as the bone biochemical markers type I collagen C-telopeptide for bone resorption and osteocalcin and bone alkaline phosphatase for bone formation, were analysed before and after a maximal incremental exercise test.
  
  
  RESULTS
  At basal level, iPTH was positively correlated with age (r = 0.56, p < 0.01) and negatively correlated with 25(OH)D (r = -0.50; p < 0.01) and 1.25(OH)2D3 (r = -0.47; p < 0.05). Moreover, 25(OH)D and 1.25(OH)2D3 levels were negatively correlated with age (r = -0.50, p < 0.01 and r = -0.53, p < 0.01, respectively). After exercise, iCa and 25(OH)D decreased (p < 0.001 and p = 0.01, respectively) while iPTH increased (p < 0.001). The levels of 1.25(OH)2D3, bone biochemical markers, haematocrit, and haemoglobin were unchanged. The variations in iCa and 25(OH)D were not related to age and/or sex. The iPTH variation was directly related to basal iPTH levels (p < 0.01) and indirectly related to age.
  
  
  CONCLUSIONS
  In active elderly subjects, strenuous exercise disturbed calcium homeostasis and bone related hormones without immediate measurable effect on bone turnover. Although an increase in iPTH could have an anabolic action on bone tissue, our findings from our short term study did not allow us to conclude that such action occurred.
authors.affiliation: Laboratoire de Physiologie des Interactions UPRES EA 701, CHU Arnaud de Villeneuve, Montpellier, France. laurent.maimoun@oreka.com
authors.forename: L
authors.initials: L
authors.lastname: Maïmoun
authors.forename: D
authors.initials: D
authors.lastname: Simar
authors.forename: D
authors.initials: D
authors.lastname: Malatesta
authors.forename: C
authors.initials: C
authors.lastname: Caillaud
authors.forename: E
authors.initials: E
authors.lastname: Peruchon
authors.forename: I
authors.initials: I
authors.lastname: Couret
authors.forename: M
authors.initials: M
authors.lastname: Rossi
authors.forename: D
authors.initials: D
authors.lastname: Mariano-Goulart
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D015992:Body Mass Index; D001862:Bone Resorption / Q000378:metabolism; D001842:Bone and Bones / Q000378:metabolism*; D002118:Calcium / Q000097:blood; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005260:Female; D006706:Homeostasis / Q000502:physiology; D006728:Hormones / Q000097:blood*; D006801:Humans; D006887:Hydroxycholecalciferols / Q000097:blood; D008297:Male; D008875:Middle Aged; D015675:Osteocalcin / Q000032:analysis; D010012:Osteogenesis / Q000502:physiology; D010101:Oxygen Consumption / Q000502:physiology; D010281:Parathyroid Hormone / Q000097:blood; D016138:Walking / Q000502:physiology*
chemical_list: D015415:Biomarkers; D006728:Hormones; D006887:Hydroxycholecalciferols; D010281:Parathyroid Hormone; D015675:Osteocalcin; D002118:Calcium